Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
0,0050 CA$
0,00%
(0,00) 1D
28 ოქტ, 13:31:29 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285,35 ათ.
Avg. vol.
806,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
14,27
Shares outstanding
57,07 მლნ.
Mkt. cap
285,35 ათ.
Avg. vol.
806,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
14,27
Shares outstanding
57,07 მლნ.
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
Headquartersვანკუვერი, ბრიტანეთის კოლუმბია, კანადა
SectorHealth Care
Industry-
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,77 ათ.
2,06 ათ.
2,95 ათ.
1,58 ათ.
Operating expense
34,77 ათ.
2,06 ათ.
2,95 ათ.
1,58 ათ.
Total operating expenses
34,77 ათ.
2,06 ათ.
2,95 ათ.
1,58 ათ.
Operating income
-34,77 ათ.
-2,06 ათ.
-2,95 ათ.
-1,58 ათ.
Other non operating income
-2,27 ათ.
-1,16 ათ.
-10,54 ათ.
-1,91 ათ.
EBT including unusual items
-39,64 ათ.
-5,83 ათ.
-16,55 ათ.
-6,82 ათ.
EBT excluding unusual items
-39,64 ათ.
-5,83 ათ.
-16,55 ათ.
-6,82 ათ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39,64 ათ.
-5,83 ათ.
-16,55 ათ.
-6,82 ათ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,61 ათ.
-2,61 ათ.
-3,06 ათ.
-3,33 ათ.
Net interest expenses
-2,61 ათ.
-2,61 ათ.
-3,06 ათ.
-3,33 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 ათ.
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები